IDEXX Laboratories Inc. - SCHEDULE 13G/A Filing

This filing, an amendment (15) to a Schedule 13G, concerns IDEXX Laboratories Inc. The Vanguard Group, a registered investment advisor, holds 0 shares, representing 0% ownership. Previously, Vanguard held 9,945,328 shares. The filing indicates that Vanguard no longer holds or is deemed to hold beneficial ownership over securities held by certain subsidiaries following an internal realignment on January 12, 2026. These subsidiaries continue to pursue the same investment strategies. Vanguard certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.